Latest 23andMe Stories
23andMe, Inc., a leading personal genetics company, has announced the first-time discovery of the potentially protective nature of the gene serum/glucocorticoid regulated kinase 1 (SGK1) which appears to be protective against a high-risk leucine-rich repeat kinase 2 (LRRK2) mutation for Parkinson’s disease (PD).
23andMe, Inc., a leading personal genetics company has replicated over 180 genetic associations from a list of associations curated by the National Human Genome Research Instituteâ€™s Office of Population Genomics ("GWAS Catalog") demonstrating that self-reported medical data is effective and reliable to validate known genetic associations.
If met, Challenge will take total Brin Wojcicki Foundation giving to $130 million NEW YORK, May 31, 2011 /PRNewswire-USNewswire/ --Sergey Brin and Anne Wojcicki announced a $50-million challenge spurring existing and new donors at every level to give, or increase giving, to The Michael J.
An investigation into direct-to-consumer (DTC) genetic tests found flawed and inaccurate results, with each one giving different results, and in some cases arriving at medical predictions that were no more accurate than flipping a coin.
23andMe has released its first annual list of what it felt to be the 10 most interesting and significant genetic findings in 2010, as part of an ongoing journey to understand the role of genetics in personal health and human development.
Firefox browser extension links usersâ€™ 23andMe SNP information to web content, connecting personal genome to web with a click Reston, VA (PRWEB) January 11, 2011 5AM Solutions, a life science software engineering firm, announces the release of SNPTips, a Firefox browser plug-in that connects a userâ€™s 23andMe personal genetic information to web content with a single mouse click.
MOUNTAIN VIEW, Calif., Jan. 7, 2011 /PRNewswire/ -- 23andMe, a leading personal genomics company, today announced the addition of approximately $9 million to its Series C Financing to bring the total raised in the round to approximately $31 million.
MOUNTAIN VIEW, Calif., Nov. 9, 2010 /PRNewswire/ -- 23andMe, Inc., a leading personal genetics company, announced today the closing of its Series C financing.
Thousands of the world's top scientists and clinicians in the human genetics field will convene to present their latest research findings at the American Society of Human Genetics 60th Annual Meeting, which will be held November 2-6, 2010, in Washington, D.C.
- A gift; a largess; a gratuity; a present; a dole.